Michael Schmitz Analyst Performance

Michael Schmitz is a stock analyst at Guggenheim focused in the energy sector, covering 8 publicly traded companies. Over the past year, Michael Schmitz has issued 1 stock ratings, including and buy recommendations. While full access to Michael Schmitz's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Michael Schmitz's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

8 Last 8 Years

Buy Recommendations

100.00% 8 Buy Ratings

Companies Covered

8 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	100.0%	8 ratings
Hold	0.0%	0 ratings
Sell	0.0%	0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

• Best Call

  000.0%

  COG

  Apr 2018

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  EQT

  Aug 2018

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NYSE	75.0% of companies on NYSE	6 companies
NASDAQ	25.0% of companies on NASDAQ	2 companies

Michael Schmitz, an analyst at Guggenheim, currently covers 8 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Energy 7 companies	87.5%
	Medical 1 company	12.5%

Michael Schmitz of Guggenheim specializes in stock coverage within the Energy sector, with additional focus on Medical companies.

Coverage Industries

Industry	Percentage
OIL - US EXP&PROD 2 companies	25.0%
CRUDE PETROLEUM & NATURAL GAS 2 companies	25.0%
MED - BIOMED/GENE 1 company	12.5%
PIPELINES, EXCEPT NATURAL GAS 1 company	12.5%
DRILLING OIL & GAS WELLS 1 company	12.5%
OIL - US INTEGRTD 1 company	12.5%

Michael Schmitz's Ratings History at Guggenheim

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
EXEL Exelixis	7/29/2025	Reiterated Rating	$37.59	$45.00	Buy	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.